Log on/register
BioMed Central home | Journals A-Z | Feedback | Support | My details

Email this article to a friend

Comparison of three rapamycin dosing schedules in A/J Tsc2+/- mice and improved survival with angiogenesis inhibitor or asparaginase treatment in mice with subcutaneous tuberous sclerosis related tumors

Chelsey Woodrum email, Alison Nobil email and Sandra L Dabora email

Journal of Translational Medicine 2010, 8:14doi:10.1186/1479-5876-8-14

Your name*
Your email address*
Recipient's email address*
(multiple email addresses should be separated with commas)
Email format
Please type your message into the box below:
Terms and Conditions Privacy statement Information for advertisers Jobs at BMC Contact us
© 1999-2010 BioMed Central Ltd unless otherwise stated. Part of Springer Science+Business Media.